#IPF #ArkBio #AK3280

ArkBio Shares Promising Phase II Results for Novel IPF Treatment AK3280

ArkBio Reports Positive Phase II Results for AK3280 in IPF Treatment



Shanghai Ark Biopharmaceutical Co., Ltd. (

Topics Other）

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.